Interleukin interrupted: A new strategy for the treatment of pancreatic cancer

Steven D. Leach

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)284
Number of pages1
JournalJournal of Experimental Medicine
Volume212
Issue number3
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Interleukin-17 Receptors
Interleukin-17
Interleukins
Pancreatic Neoplasms
Chemokines
Monoclonal Antibodies

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Interleukin interrupted : A new strategy for the treatment of pancreatic cancer. / Leach, Steven D.

In: Journal of Experimental Medicine, Vol. 212, No. 3, 2015, p. 284.

Research output: Contribution to journalArticle

@article{e5f044956bae41deb482ff3866239ba1,
title = "Interleukin interrupted: A new strategy for the treatment of pancreatic cancer",
author = "Leach, {Steven D.}",
year = "2015",
doi = "10.1084/jem.2123insight1",
language = "English (US)",
volume = "212",
pages = "284",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - Interleukin interrupted

T2 - A new strategy for the treatment of pancreatic cancer

AU - Leach, Steven D.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84924706154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924706154&partnerID=8YFLogxK

U2 - 10.1084/jem.2123insight1

DO - 10.1084/jem.2123insight1

M3 - Article

C2 - 25754118

AN - SCOPUS:84924706154

VL - 212

SP - 284

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 3

ER -